Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Teva Pharmaceuticals USA Inc.
Current Parent CompanyTeva Pharmaceutical Industries
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $512,000,000
Year: 2015
Date: October 15, 2015
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Teva Pharmaceuticals and its subsidiaries Cephalon Inc. and Barr Pharmaceuticals agreed to pay $512 million to direct purchaser plaintiffs to settle litigation alleging they participated in an arrangement to delay the introduction of a generic version of the narcolepsy drug Provigil.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Pennsylvania
Civil or Criminal Case: civil
Case ID: 2:06cv1797
Case Name: King Drug Company of Florence, Inc vs. Cephalon, Inc., et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Israel
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Link to PACER Case Docket (must be logged in)(click here)
Link to Archived Court Document subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.